The partners intend to study the "clinical validity" of genetic diagnostics for certain diseases, and to discover correlations between genetic variation and disease phenotypes, the company said.
Correlagen said it will also provide sequence-based diagnostic assays to investigators at Children's Hospital for research purposes.
The company said it has the right to commercialize any diagnostic tests that arise from certain of these research programs.